Nasal nitric oxide (nNO) may be a proxy for NO or NO synthase (NOS) availability in the brain, while NO/NOS availability is likely related to metabolism and downstream to neurocognitive function. We tested this hypothesis using a mediation analysis with nNO the independent variable, regional CBF (rCBF) as measured by ASL the mediator, and neurocognitive outcome (NIH Toolbox) the dependent variable in a cohort of normal adolescents and adolescents with congenital heart disease. Anterior and posterior default mode network regions positively mediated all NIH Toolbox composite scores, especially crystallized cognition. Results indicate nNO may be a powerful biomarker for brain function and metabolism.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords